Skip to Main Content

Author Details

Mary E Moreno
San Francisco General Hospital, University of California
1996
23
18
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
33975958Genetically edited CD34[+] cells derived from human iPS cells in vivo but not in vitro engraft and differentiate into HIV-resistant cells.Proc Natl Acad Sci U S A2021
32511497Test performance evaluation of SARS-CoV-2 serological assays.medRxiv2020
32855547Evaluation of SARS-CoV-2 serology assays reveals a range of test performance.Nat Biotechnol2020
32294445Immunotherapeutic Blockade of CD47 Inhibitory Signaling Enhances Innate and Adaptive Immune Responses to Viral Infection.Cell Rep2020
30871222Cellular HIV Reservoirs and Viral Rebound from the Lymphoid Compartments of 4'-Ethynyl-2-Fluoro-2'-Deoxyadenosine (EFdA)-Suppressed Humanized Mice.Viruses2019
25670669CD8-positive lymphocytes in graft-versus-host disease of humanized NOD.Cg-Prkdc(scid)Il2rg(tm1Wjl)/SzJ mice.J Comp Pathol2015
25941222Oral administration of the nucleoside EFdA (4'-ethynyl-2-fluoro-2'-deoxyadenosine) provides rapid suppression of HIV viremia in humanized mice and favorable pharmacokinetic properties in mice and the rhesus macaque.Antimicrob Agents Chemother2015
24971704Efficacy of broadly neutralizing monoclonal antibody PG16 in HIV-infected humanized mice.Virology2014
21684569Superior human leukocyte reconstitution and susceptibility to vaginal HIV transmission in humanized NOD-scid IL-2Rγ(-/-) (NSG) BLT mice.Virology2011
17668043Validation of the SCID-hu Thy/Liv mouse model with four classes of licensed antiretrovirals.PLoS One2007
12525647Human immunodeficiency virus type 1 Nef-mediated downregulation of CD4 correlates with Nef enhancement of viral pathogenesis.J Virol2003
11751977IFN-alpha secretion by type 2 predendritic cells up-regulates MHC class I in the HIV-1-infected thymus.J Immunol2002
11606733SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo.Proc Natl Acad Sci U S A2001
10681360Antiviral activity of 2'-deoxy-3'-oxa-4'-thiocytidine (BCH-10652) against lamivudine-resistant human immunodeficiency virus type 1 in SCID-hu Thy/Liv mice.Antimicrob Agents Chemother2000
10954574Coinfection of SCID-hu Thy/Liv mice with human herpesvirus 6 and human immunodeficiency virus type 1.J Virol2000
10601360Experimental transmission of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) to SCID-hu Thy/Liv mice.J Exp Med1999
10438873R5 strains of human immunodeficiency virus type 1 from rapid progressors lacking X4 strains do not possess X4-type pathogenicity in human thymus.J Virol1999
10377191Human herpesvirus 6 (HHV-6) causes severe thymocyte depletion in SCID-hu Thy/Liv mice.J Exp Med1999
9811751CCR5- and CXCR4-utilizing strains of human immunodeficiency virus type 1 exhibit differential tropism and pathogenesis in vivo.J Virol1998
9531575Human immunodeficiency virus-1 infection interrupts thymopoiesis and multilineage hematopoiesis in vivo.Blood1998
9687417Inhibition of human immunodeficiency virus type 1 infection in SCID-hu Thy/Liv mice by the G-quartet-forming oligonucleotide, ISIS 5320.Antimicrob Agents Chemother1998
8851605Antiviral efficacy in vivo of the anti-human immunodeficiency virus bicyclam SDZ SID 791 (JM 3100), an inhibitor of infectious cell entry.Antimicrob Agents Chemother1996
8851606Use of standardized SCID-hu Thy/Liv mouse model for preclinical efficacy testing of anti-human immunodeficiency virus type 1 compounds.Antimicrob Agents Chemother1996
  • 1 - 23 of 23

Recommended Authors

Louise E Hogan
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 3
Jocelyn T Kim
University of California Los Angeles
Career Start Year 2011
Number of shared co-authors 0
Chi N Chan
Vaccine & Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2010
Number of shared co-authors 0
Amy L Ellis-Connell
University of Wisconsin
Career Start Year 2010
Number of shared co-authors 0
Kei Sato
The Institute of Medical Science, The University of Tokyo
Career Start Year 2008
Number of shared co-authors 1
Jacob D Estes
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 2002
Number of shared co-authors 2
Alberto Bosque
George Washington University
Career Start Year 2000
Number of shared co-authors 2
Jason M Brenchley
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 2000
Number of shared co-authors 2
Maudi Killian
University of California San Francisco
Career Start Year 1999
Number of shared co-authors 0
Sharon R Lewin
The University of Melbourne at the Peter Doherty Institute for Infection and Immunity
Career Start Year 1993
Number of shared co-authors 3
Lubbertus C F Mulder
Icahn School of Medicine at Mount Sinai
Career Start Year 1993
Number of shared co-authors 1
Ulf Dittmer
University Hospital Essen, University of Duisburg-Essen, Institute for Virology
Career Start Year 1993
Number of shared co-authors 3
Vicente Planelles
University of Utah
Career Start Year 1991
Number of shared co-authors 2
Mark Connors
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1990
Number of shared co-authors 3
Bruce D Walker
Ragon Institute of Mass General
Career Start Year 1987
Number of shared co-authors 5
Olivier Schwartz
Institut Pasteur, Universite Paris Cite, CNRS UMR9
Career Start Year 1987
Number of shared co-authors 4
Mohan Somasundaran
University of Massachusetts Chan Medical School
Career Start Year 1985
Number of shared co-authors 2
Richard T Davey
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1985
Number of shared co-authors 0
Stephen Raffanti
Vanderbilt University Medical Center
Career Start Year 1983
Number of shared co-authors 0
Michael Emerman
Fred Hutchinson Cancer Center
Career Start Year 1982
Number of shared co-authors 4
Rafick-Pierre Sekaly
Pathology Advanced Translational Research Unit, Emory University School of Medicine
Career Start Year 1981
Number of shared co-authors 3
Henry Clifford Lane
Division of Clinical Research, National Institutes of Allergy and Infectious Diseases
Career Start Year 1981
Number of shared co-authors 1
Louis J Picker
Vaccine and Gene Therapy Institute, Oregon Health & Science University
Career Start Year 1980
Number of shared co-authors 2
Steven M Wolinsky
Northwestern University Feinberg School of Medicine
Career Start Year 1979
Number of shared co-authors 4
Robert F Siliciano
Johns Hopkins University School of Medicine
Career Start Year 1978
Number of shared co-authors 2
Jeffrey D Lifson
Frederick National Laboratory
Career Start Year 1977
Number of shared co-authors 3
Ronald J Messer
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1972
Number of shared co-authors 3
Ruth M Ruprecht
University of Texas San Antonio
Career Start Year 1971
Number of shared co-authors 0
Douglas D Richman
Center for AIDS Research, University of California San Diego
Career Start Year 1970
Number of shared co-authors 1
Luis J Montaner
Wistar Institute
Career Start Year 1958
Number of shared co-authors 0

Collaborators

Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
Co-authored papers 2
Jonathan M Woo
University of California san francisco
Co-authored papers 2
Tori N Yamamoto
National Cancer Institute
Co-authored papers 2
Wei Gu
University of California San Francisco
Co-authored papers 2
Andrew G Levine
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Ruby Yu
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
Richelle C Charles
Massachusetts General Hospital
Co-authored papers 2
Brian R Shy
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
Joanna Balcerek
University of California San Francisco
Co-authored papers 2
Anthony J Iafrate
Massachusetts General Hospital
Co-authored papers 2
Alexander Marson
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
Michael R Wilson
Weill Institute for Neurosciences, University of California-San Francisco
Co-authored papers 2
Cody T Mowery
University of California san francisco
Co-authored papers 2
Jeffrey D Whitman
University of California San Francisco School of Medicine
Co-authored papers 2
Lila A Farrington
University of California san francisco
Co-authored papers 2
Dianna L Ng
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Charles Y Chiu
University of California-San Francisco
Co-authored papers 2
Justine Levan
University of California San Francisco
Co-authored papers 2
Youjin V Lee
University of Chicago
Co-authored papers 2
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 2
Edward T Ryan
Massachusetts General Hospital
Co-authored papers 2
Gregory M Goldgof
University of California san francisco
Co-authored papers 2
Jackie Chan
University of California san francisco
Co-authored papers 2
Antonia E Gallman
Yale University School of Medicine
Co-authored papers 2
Trisha A Macrae
University of California san francisco
Co-authored papers 2
Zachary Steinhart
Gladstone-UCSF Institute of Genomic Immunology
Co-authored papers 2
Eva M Gillis-Buck
University of California san francisco
Co-authored papers 2
Than S Kyaw
University of California san francisco
Co-authored papers 2
Jason G Cyster
University of California san francisco
Co-authored papers 2
Aashish Manglik
Department of Pharmaceutical Chemistry, University of California San Francisco
Co-authored papers 2
Release 1.2